✦ LIBER ✦

Evaluation of Recombinant Human Interleukin-12 in Patients with Recurrent or Refractory Ovarian Cancer: A Gynecologic Oncology Group Study

✍ Scribed by Jean A Hurteau; John A Blessing; Steven L DeCesare; William T Creasman

Book ID: 112248551
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 41 KB
Volume: 82
Category: Article
ISSN: 0090-8258
DOI: 10.1006/gyno.2001.6255

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cyclosporin enhancement of cisplatin che

Cyclosporin enhancement of cisplatin chemotherapy in patients with refractory gynecologic cancer. A gynecologic oncology group study

✍ Alberto Manetta; Julie Boyle; Michael L. Berman; Philip J. Disaia; Samuel Lentz; 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 370 KB 👁 2 views

Cyclosporin enhancement of cisplatin che

Cyclosporin enhancement of cisplatin chemotherapy in patients with refractory gynecologic cancer: A gynecologic oncology group study

✍ A. Manetta; M. Berman; J. Boyle; P.J. DiSaia; S. Lentz; S.Y. Liao; D. Mutch; L. 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Phase II Trial of Bevacizumab in Persist

Phase II Trial of Bevacizumab in Persistent or Recurrent Epithelial Ovarian Cancer or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study

✍ Burger, R. A.; Sill, M. W.; Monk, B. J.; Greer, B. E.; Sorosky, J. I. 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 112 KB

A phase II evaluation of bortezomib in t

A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: A Gynecologic Oncology Group study

✍ Carol Aghajanian; John A. Blessing; Kathleen M. Darcy; Gary Reid; Koen DeGeest; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 589 KB

A phase II evaluation of mifepristone in

A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: A gynecologic oncology group study

✍ Thomas F. Rocereto; William E. Brady; Mark S. Shahin; James S. Hoffman; Laurie S 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 162 KB

A randomized phase II evaluation of bryo

A randomized phase II evaluation of bryostatin-1 (NSC #339555) in recurrent or persistent platinum-sensitive ovarian cancer: A Gynecologic Oncology Group Study

✍ Deborah K. Armstrong; John A. Blessing; Katherine Y. Look; Russell Schilder; Eve 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 62 KB